TMC Wound Care Center achieved outstanding clinical outcomes for 12 consecutive months, including patient satisfaction higher than 92 percent, and a wound healing rate of at least 91 percent in fewer than 31 median days. The Center joins 334 across the country in achieving this honor in 2017.
“The entire team has put in a tremendous effort all year long to improve upon excellent patient outcomes and to achieve our Center of Distinction goal,” said Heather Jankowski, the Center’s director.
TMC Wound Care Center offers highly-specialized wound care to patients suffering from diabetic ulcers, pressure ulcers, infections and other chronic wounds that have not healed in a reasonable amount of time. Some of the leading-edge treatments offered at the Wound Care Center include negative pressure wound therapy, debridement, application of cellular-based tissue or skin substitutes to the wound, hyperbaric oxygen therapy and offloading or total contact casts.
The Center’s medical director, Dr. Michael Lavor, applauded the work of the team. “It is an incredible honor to be designated as Center of Distinction and is a reflection of the hard work from the entire staff as we continue to provide excellent care to the community.”
About the Wound Care Center
The TMC Outpatient Wound Care Center has been operational for five years. With five exam rooms and four hyperbaric oxygen chambers, the Center treats a wide variety of patients with problems such as diabetic foot ulcer, venous stasis ulcers, failed flaps, and ORN of the jaw. The Outpatient Wound Care Center looks forward to expanding to 10 exam rooms within the next few weeks.
About Healogics, Inc.
Headquartered in Jacksonville, Fla., Healogics is the nation’s largest provider of advanced wound care services. Healogics and its affiliated companies manage nearly 800 Wound Care Centers in the nation and saw over 300,000 new patients in 2016 through a connected network of partner hospitals and Wound Care Centers, academic medical centers, and other post‐acute sites. Healogics utilizes an evidence‐based systematic approach to chronic wound healing to treat an underserved and growing patient population. A fund managed by Clayton, Dubilier & Rice, a private investment firm, is the majority shareholder of Healogics. For more information, please visit www.healogics.com.